Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines
NCT02882893 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 238
Last updated 2016-08-30
Summary
The purpose of this study is to evaluate the Efficacy and Safety of DWP450 treatment of Crows Feet Lines(CFL).
Conditions
- Crows Feet Lines
Interventions
- DRUG
-
Clostridium Botulinum A Toxin
- DRUG
-
Clostridium Botulinum A Toxin
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet
NCT04818203 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
BOTOX® in the Treatment of Crow's Feet Lines in China
NCT02195687 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines
NCT03408236 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET)
NCT01308060 ·Status: COMPLETED ·Phase: PHASE3
-
Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study
NCT01529788 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines
NCT04081402 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01940991 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines
NCT05292638 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective, Multicenter, Blind, Randomized Controlled, Optimal Clinical Trial to Evaluate the Safety and Efficacy of Medical Collagen Fillers for Facial Dermal Tissue Filling to Correct Frontal Wrinkles (crow's Feet)
NCT06703294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet
NCT01358695 ·Status: COMPLETED ·Phase: PHASE2
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
NCT02677298 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
NCT04225260 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement
NCT06402058 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial
NCT05804656 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction
NCT04439825 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01776606 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Moderate to Severe Glabellar Lines
NCT04249583 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin to Improve Lower Blepharoplasty Scar
NCT02786550 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial to Evaluate Safety and Efficacy of Ultherapy™ System for Lifting Skin on the Neck
NCT02368925 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles
NCT07072806 ·Status: COMPLETED ·Phase: PHASE4
-
Sculptra for Décolletage Crepiness and Wrinkling
NCT03508973 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines
NCT05364580 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines
NCT01791920 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
NCT05217355 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
NCT01391312 ·Status: COMPLETED ·Phase: PHASE4